Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ <i>neu</i> Oncogene

Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · see citing works

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817 · see citing works

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

Ullrich, A., Coussens, L. M., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,751 · see citing works

Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene

Coussens, L. M., Yang‐Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J. P., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,815 · see citing works

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

Guy, C. T., Cardiff, R., & Muller, W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954-961.1992 · Cited by 1,710 · see citing works

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,523 · see citing works

Requirement for neuregulin receptor erbB2 in neural and cardiac development

Lee, K., Simon, H. H., Chen, H., Bates, B., Hung, M., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,291 · see citing works

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246 · see citing works

Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

Yamamoto, T. S., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204 · see citing works

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Guy, C. T., Webster, M. A., Schaller, M. D., Parsons, T. J., Cardiff, R. D., & Muller, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193 · see citing works

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,177 · see citing works

The neu oncogene encodes an epidermal growth factor receptor-related protein

Bargmann, C. I., Hung, M., & Weinberg, R. A. (1986) · Nature · doi:10.1038/319226a0 · Cited by 1,115 · see citing works

The biology of erbB-2/nue/HER-2 and its role in cancer

Hynes, N. E. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90012-4 · Cited by 974 · see citing works

Neu-Protein Overexpression in Breast Cancer

van de Vijver, M. J., Peterse, J. L., Mooi, W. J., Wisman, P., Lomans, J., Dalesio, O., & Nusse, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191902 · Cited by 860 · see citing works

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

Xu, X., Wagner, K., Larson, D. M., Ohler, Z. W., Li, C., Ried, T., Hennighausen, L. G., Wynshaw-Boris, A. J., & Deng, C. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758 · see citing works

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.

Kraus, M. H., Issing, W. J., Takashi, M. I. K. I., Popescu, N. C., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9193 · Cited by 737 · see citing works

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.

Plowman, G. D., Culouscou, J., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., NEUBAUER, M., & SHOYAB, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 714 · see citing works

Gene Targeting: A Practical Approach

Hirst, M. C. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 593 · see citing works

Cre-mediated gene deletion in the mammary gland

Wagner, K., Wall, R. J., St‐Onge, L., Gruss, P., Wynshaw-Boris, A. J., Garrett, L. J., Li, M., Furth, P. A., & Hennighausen, L. G. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4323 · Cited by 518 · see citing works

OSTEOGENESIS IMPERFECTA IS LINKED TO BOTH TYPE I COLLAGEN STRUCTURAL GENES

Sykes, B. C., Wordsworth, B. P., Ogilvie, D., Anderson, J., & Jones, N. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91609-0 · Cited by 444 · see citing works

Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

Siegel, P. M., Ryan, E. D., Cardiff, R. D., & Muller, W. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442 · see citing works

Steroid hormone receptors in breast cancer management

Osborne, C. K. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006132427948 · Cited by 438 · see citing works

OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION

Venter, D., Kumar, S., Tuzi, N. L., & Gullick, W. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92736-x · Cited by 405 · see citing works

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

Bouchard, L., Lamarre, L., Tremblay, P. J., & Jolicoeur, P. (1989) · Cell · doi:10.1016/0092-8674(89)90331-0 · Cited by 393 · see citing works

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.

Plowman, G. D., Whitney, G. S., NEUBAUER, M., Green, J. M., McDonald, V. L., Todaro, G. J., & SHOYAB, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.4905 · Cited by 366 · see citing works

Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion.

Bargmann, C. I., & Weinberg, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03044.x · Cited by 317 · see citing works

Novel Activating Mutations in the neu Proto-oncogene Involved in Induction of Mammary Tumors

Siegel, P. M., Dankort, D. L., Hardy, W. R., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7068-7077.1994 · Cited by 213 · see citing works

Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis

Webster, M. A., Hutchinson, J. N., Rauh, M. J., Muthuswamy, S. K., Anton, M., Tortorice, C. G., Cardiff, R. D., Graham, F. L., Hassell, J. A., & Muller, W. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2344 · Cited by 200 · see citing works

Targeted c‐myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.

Schoenenberger, C., Andres, A. ‐., Groner, B., van der Valk, M., LeMeur, M., & GERLINGER, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02797.x · Cited by 199 · see citing works

The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.

Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., & Greene, M. I. (1994) · PubMed · Cited by 180 · see citing works

Bacteriophage P1 cre gene and its regulatory region

Sternberg, N., Sauer, B., Hoess, R., & Abremski, K. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90228-7 · Cited by 171 · see citing works

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

Zeillinger, R., Kury, F., Czerwenka, K. F., Kubista, E., Sliutz, G., Knogler, W., Huber, J., Zielinski, C. C., Reiner, G. C. A., & Jakesz, R. (1989) · PubMed · Cited by 150 · see citing works

Activated neu Induces Rapid Tumor Progression

Guy, C. T., Cardiff, R. D., & Muller, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7673 · Cited by 145 · see citing works

A novel splice variant ofHER2 with increased transformation activity

Kwong, K. Y., & Hung, M. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199810)23:2 · Cited by 139 · see citing works

Lobulo-Alveolar Development of Mouse Mammary Glands Is Regulated by Thyroid Hormones

Vonderhaar, B. K., & Greco, A. E. (1979) · Endocrinology · doi:10.1210/endo-104-2-409 · Cited by 116 · see citing works

Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization.

Ishikawa, T., Kobayashi, M., Mai, M., Suzuki, T., & Ooi, A. (1997) · Europe PMC (PubMed Central) · Cited by 95 · see citing works

An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice

Stöcklin, E., Botteri, F. M., & Groner, B. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.199 · Cited by 88 · see citing works

HER-2/neuOncogene Amplification by Fluorescence In Situ Hybridization in Epithelial Tumors of the Ovary

Ross, J. S., Yang, F., Kallakury, B., Sheehan, C. E., Ambros, R. A., & Muraca, P. J. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.3.311 · Cited by 72 · see citing works

Differential expression of the neu transgene in murine mammary tissues

Deckard-Janatpour, K., Muller, W. J., Chodosh, L. A., Gardner, H. P., Marquis, S. T., Coffey, R. N. T., & Cardiff, R. D. (1997) · International Journal of Oncology · doi:10.3892/ijo.11.2.235 · Cited by 11 · see citing works

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

Cappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S. E., Danenberg, K. D., Domenichini, I., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,538 · see citing works

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,229 · see citing works

ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics

Arteaga, C. L., & Engelman, J. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.025 · Cited by 1,048 · see citing works

Modelling breast cancer: one size does not fit all

Vargo-Gogola, T. C., & Rosen, J. M. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2193 · Cited by 681 · see citing works

Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis

Grünert, S., Jechlinger, M., & Beug, H. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1175 · Cited by 677 · see citing works

Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA lossPreprint

Arun, G., Diermeier, S. D., Akerman, M., Chang, K.-C., Wilkinson, J. E., Hearn, S., Kim, Y., MacLeod, A. R., Krainer, A. R., Norton, L., et al. (2015) · Genes & Development · doi:10.1101/gad.270959.115 · Cited by 586 · see citing works

Oncogenes and Tumor Suppressor GenesPreprint

Lee, E. Y., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 515 · see citing works

Pten in stromal fibroblasts suppresses mammary epithelial tumours

Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A. S., Creasap, N., Thompson, J. C., Caserta, E., Wang, H., Chong, J.-L., et al. (2009) · Nature · doi:10.1038/nature08486 · Cited by 501 · see citing works

Structure–function relationship of estrogen receptor α and β: Impact on human health

Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 503 · see citing works

Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors

Politi, K., Zakowski, M. F., Fan, P.-D., Schonfeld, E. A., Pao, W., & Varmus, H. E. (2006) · Genes &amp; Development · doi:10.1101/gad.1417406 · Cited by 478 · see citing works

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

Stingl, J., & Caldas, C. (2007) · Nature Reviews. Cancer · doi:10.1038/nrc2212 · Cited by 518 · see citing works

Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction

White, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413 · see citing works

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402 · see citing works

Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.

Flesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 271 · see citing works

Insights from transgenic mouse models of ERBB2-induced breast cancer

Ursini‐Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2127 · Cited by 270 · see citing works

Effect of Conditional Knockout of the Type II TGF-β Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis

Forrester, E., Chytil, A., Bierie, B., Aakre, M. E., Gorska, A. E., Sharif‐Afshar, A., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 248 · see citing works

Par6–aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control

Aranda, V., Haire, T., Nolan, M. E., Calarco, J. P., Rosenberg, A. Z., Fawcett, J. P., Pawson, T. J., & Muthuswamy, S. K. (2006) · Nature Cell Biology · doi:10.1038/ncb1485 · Cited by 243 · see citing works

MCL-1 is a prognostic indicator and drug target in breast cancer

Campbell, K. J., Dhayade, S., Ferrari, N., Sims, A. H., Johnson, E. R., Mason, S. M., Dickson, A., Ryan, K. M., Kalna, G., Edwards, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0035-2 · Cited by 203 · see citing works

Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression

Lahlou, H., Sanguin‐Gendreau, V., Zuo, D., Cardiff, R. D., McLean, G. W., Frame, M. C., & Muller, W. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710091104 · Cited by 196 · see citing works

Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression

Dillon, R. L., Marcotte, R., Hennessy, B. T., Woodgett, J. R., Mills, G. B., & Muller, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4287 · Cited by 169 · see citing works

Pathway Pathology

Rosner, A., Miyoshi, K., Landesman‐Bollag, E., Xu, X., Seldin, D. C., Moser, A. R., MacLeod, C. L., Shyamala, G., Gillgrass, A. E., & Cardiff, R. D. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64269-1 · Cited by 165 · see citing works

Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer

Dankort, D. L., Maślikowski, B. M., Warner, N. E., Kanno, N., Kim, H. L., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1540-1551.2001 · Cited by 163 · see citing works

Loss of Par3 promotes breast cancer metastasis by compromising cell–cell cohesion

Xue, B., Krishnamurthy, K., Allred, D. C., & Muthuswamy, S. K. (2012) · Nature Cell Biology · doi:10.1038/ncb2663 · Cited by 159 · see citing works

Lysyl Oxidase–like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer

Salvador, F., Martín, A. L., López‐Menéndez, C., Moreno‐Bueno, G., Santos, V., Vázquez-Naharro, A., Santamarı́a, P. G., Morales, S., Dubus, P. R., Muinelo‐Romay, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3152 · Cited by 152 · see citing works

Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis

Farrell, A. S., Pelz, C., Wang, X., Daniel, C. J., Wang, Z., Su, Y., Janghorban, M., Zhang, X., Morgan, C. W., Impey, S., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01455-12 · Cited by 140 · see citing works

Transgenic mouse models of human breast cancer

Hutchinson, J. N., & Muller, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203970 · Cited by 143 · see citing works

Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

Wang, J., Li, B., Luo, M., Huang, J., Zhang, K., Zheng, S., Zhang, S., & Zhou, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01779-3 · Cited by 149 · see citing works

Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors

Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311887200 · Cited by 132 · see citing works

The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies

Freudenberg, J. A., Wang, Q., Katsumata, M., Drebin, J. A., Nagatomo, I., & Greene, M. I. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.05.001 · Cited by 127 · see citing works

Transforming Growth Factor–β Regulates Mammary Carcinoma Cell Survival and Interaction with the Adjacent Microenvironment

Bierie, B., Stover, D. G., Abel, T. W., Chytil, A. M., Gorska, A. E., Aakre, M. E., Forrester, E., Yang, H. H., Wagner, K., & Moses, H. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5597 · Cited by 124 · see citing works

PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target

Li, J., Karaplis, A. C., Huang, D. C., Siegel, P. M., Camirand, A., Yang, X. F., Muller, W. J., & Kremer, R. B. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46134 · Cited by 124 · see citing works

ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival

Andrechek, E. R., Hardy, W. R., Girgis-Gabardo, A., Perry, R. L., Butler, R., Graham, F. L., Kahn, R., Rudnicki, M. A., & Muller, W. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4714-4722.2002 · Cited by 123 · see citing works

Animal models of tumor immunity, immunotherapy and cancer vaccines

Ostrand‐Rosenberg, S. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.003 · Cited by 122 · see citing works

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer

Deblois, G., Smith, H. W., Tam, I. S., Gravel, S., Caron, M., Savage, P., Labbé, D. P., Bégin, L. R., Tremblay, M. L., Park, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12156 · Cited by 120 · see citing works

Botanical and Dietary Supplements for Menopausal Symptoms: What Works, What Does Not

GELLER, S. E., & Studee, L. (2005) · Journal of Women s Health · doi:10.1089/jwh.2005.14.634 · Cited by 119 · see citing works

ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells

Muraoka, R. S., Lenferink, A. E. G., Law, B. K., Hamilton, E., Brantley, D. M., Roebuck, L. R., & Arteaga, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2204-2219.2002 · Cited by 116 · see citing works

Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network

Troyer, K. L., & Lee, D. C. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009560330359 · Cited by 114 · see citing works

Muc4/sialomucin complex, the intramembrane Er6B2 ligand, in cancer and epithelia: To protect and to survive

Carraway, K. L., Perez, A., Idris, N., Jepson, S., Arango, M. E., Komatsu, M., Haq, B., Price‐Schiavi, S. A., Zhang, J., & Carraway, C. A. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)71043-x · Cited by 111 · see citing works

Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines

Miyake, I., Hakomori, Y., Shinohara, A., Gamou, T., Saito, M., Iwamatsu, A., & Sakai, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205735 · Cited by 111 · see citing works

Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage

SAU, A. C., Lau, R., Cabrita, M. A., Nolan, E., Crooks, P. A., Visvader, J. E., & Pratt, M. A. C. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.003 · Cited by 106 · see citing works

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

Yeon, C. H., & Pegram, M. D. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-2899-8 · Cited by 101 · see citing works

The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

Fereshteh, M., Tilli, M. T., Kim, S. E., Xu, J., O’Malley, B. W., Wellstein, A., Furth, P. A., & Riegel, A. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6702 · Cited by 97 · see citing works

β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer

Lahlou, H., & Muller, W. J. (2011) · Breast Cancer Research · doi:10.1186/bcr2905 · Cited by 96 · see citing works

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Montagna, C., Andrechek, E. R., Padilla‐Nash, H. M., Muller, W. J., & Ried, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205146 · Cited by 94 · see citing works

Animal Models for Studying Prevention and Treatment of Breast Cancer

Welsh, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00040-3 · Cited by 88 · see citing works

Cooperativity of E-cadherin and Smad4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis

Park, J. W., Jang, S. H., Park, D. M., Lim, N. J., Deng, C., Kim, D.-Y., Green, J. E., & Kim, H. K. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0192-t · Cited by 82 · see citing works

eIF4F suppression in breast cancer affects maintenance and progression

Nasr, Z., Robert, F., Porco, J. A. J., Muller, W. J., & Pelletier, J. (2012) · Oncogene · doi:10.1038/onc.2012.105 · Cited by 81 · see citing works

Transcriptional Control of the ERBB2 Amplicon by ERRα and PGC-1β Promotes Mammary Gland Tumorigenesis

Deblois, G., Chahrour, G., Perry, M.-C., Sylvain-Drolet, G., Muller, W. J., & Giguère, V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2840 · Cited by 81 · see citing works

β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression

Schade, B., Lesurf, R., Sanguin‐Gendreau, V., Bui, T., Deblois, G., O’Toole, S. A., Millar, E. K. A., Zardawi, S. J., López‐Knowles, E., Sutherland, R. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3925 · Cited by 80 · see citing works

MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer

Taneja, P., Frazier, D. P., Kendig, R. D., Maglic, D., Sugiyama, T., Kai, F., Taneja, N. K., & Inoue, K. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.31 · Cited by 78 · see citing works

Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer

Knight, J. F., Lesurf, R., Zhao, H., Pinnaduwage, D., Davis, R. R., Saleh, S. M. I., Zuo, D., Naujokas, M. A., Chughtai, N., Herschkowitz, J. I., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210353110 · Cited by 75 · see citing works

A genomic analysis of mouse models of breast cancer reveals molecular features ofmouse models and relationships to human breast cancer

Hollern, D. P., & Andrechek, E. R. (2014) · Breast Cancer Research · doi:10.1186/bcr3672 · Cited by 75 · see citing works

PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis

Schade, B., Rao, T., Dourdin, N., Lesurf, R., Hallett, M. T., Cardiff, R. D., & Muller, W. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018937 · Cited by 75 · see citing works

Models of breast cancer: is merging human and animal models the future?

Kim, J. B., O’Hare, M. J., & Stein, R. C. (2003) · Breast Cancer Research · doi:10.1186/bcr645 · Cited by 74 · see citing works

Mechanisms in Epithelial Plasticity and Metastasis: Insights from 3D Cultures and Expression Profiling

Jechlinger, M., Grünert, S., & Beug, H. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1024090116451 · Cited by 74 · see citing works

Models of breast cancer: quo vadis, animal modeling?

Wagner, K. (2003) · Breast Cancer Research · doi:10.1186/bcr723 · Cited by 74 · see citing works

Mammary epithelial stem cells

Smith, G. H., & Chepko, G. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010115)52:2 · Cited by 173 · see citing works

Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth

Andrechek, E. R., White, D., & Muller, W. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208230 · Cited by 72 · see citing works

Biological and clinical significance of her2 overexpression in Breast Cancer

Kurebayashi, J. (2001) · Breast Cancer · doi:10.1007/bf02967477 · Cited by 70 · see citing works

Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia

Cardiff, R. D., Moghanaki, D. M., & Jensen, R. A. (2000) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009534129331 · Cited by 70 · see citing works

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.

Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003) · PubMed · Cited by 65 · see citing works

The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER‐2/neu transgenic mice

Anisimov, V. N., Alimova, I. N., Baturin, D. A., Popovich, I. G., Zabezhinski, M. A., Mantón, K. G., Semenchenko, A. V., & YASHIN, A. I. (2002) · International Journal of Cancer · doi:10.1002/ijc.10827 · Cited by 64 · see citing works

HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer

Ahmad, I., Patel, R., Singh, L. B., Nixon, C., Seywright, M. M., Barnetson, R. J., Brunton, V. G., Muller, W. J., Edwards, J., Sansom, O. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101263108 · Cited by 62 · see citing works

Manifestation, mechanisms and mysteries of gene amplifications

Myllykangas, S., & Knuutila, S. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.045 · Cited by 64 · see citing works

Integrated analyses of murine breast cancer models reveal critical parallels with human disease

Rennhack, J. P., To, B., Swiatnicki, M., Dulak, C., Ogrodzinski, M. P., Zhang, Y., Li, C., Bylett, E., Ross, C. R., Szczepanek, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11236-3 · Cited by 62 · see citing works

Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation

Ke, Y., Lesperance, J., Zhang, E. E., Bard-Chapeau, E. A., Oshima, R. G., Muller, W. J., & Feng, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607325200 · Cited by 61 · see citing works

Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and Migration

Diermeier, S. D., Chang, K.-C., Freier, S. M., Song, J., Demerdash, O. E., Krasnitz, A., Rigo, F., Bennett, C. F., & Spector, D. L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.081 · Cited by 59 · see citing works

Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development

Ursini‐Siegel, J., Rajput, A. B., Lu, H., Sanguin‐Gendreau, V., Zuo, D., Papavasiliou, V., Lavoie, C. A., Turpin, J., Cianflone, K., Huntsman, D. D., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00686-07 · Cited by 58 · see citing works

Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis

Marcotte, R., Smith, H. W., Sanguin‐Gendreau, V., McDonough, R. V., & Muller, W. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018861108 · Cited by 56 · see citing works

HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells

Wilson, C., Cajulis, E. E., Green, J. L., Olsen, T. M., Chung, Y.-A., Damore, M. A., Dering, J., Calzone, F. J., & Slamon, D. J. (2005) · Breast Cancer Research · doi:10.1186/bcr1343 · Cited by 54 · see citing works

Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis

Dourdin, N., Schade, B., Lesurf, R., Hallett, M. T., Munn, R. J., Cardiff, R. D., & Muller, W. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5727 · Cited by 53 · see citing works

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers

Mungamuri, S. K., Murk, W. K., Grumolato, L., Bernstein, E., & Aaronson, S. A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.009 · Cited by 52 · see citing works

Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer

Oshita, F., Matsukuma, S., Yoshihara, M., Sakuma, Y., Ohgane, N., Kameda, Y., Saito, H., Yamada, K., Tsuchiya, E., & Miyagi, Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603396 · Cited by 52 · see citing works

ErbB2 Transgenic Mice: A Tool for Investigation of the Immune Prevention and Treatment of Mammary Carcinomas

Quaglino, E., Mastini, C., Forni, G., & Cavallo, F. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im2009s82 · Cited by 51 · see citing works

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

Gao, M., Patel, R., Ahmad, I., Fleming, J., Edwards, J., McCracken, S. R., Sahadevan, K., Seywright, M. M., Norman, J. C., Sansom, O. J., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100944 · Cited by 51 · see citing works

Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling

Hodgson, J. G., Malek, T. B., Bornstein, S., Hariono, S., Ginzinger, D. G., Muller, W. J., & Gray, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0755 · Cited by 51 · see citing works

Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity

Risom, T., Wang, X., Liang, J. B., Zhang, X., Pelz, C., Campbell, L. G., Eng, J., Chin, K., Farrington, C. C., Narla, G., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126390 · Cited by 48 · see citing works

Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells

Liang, C., Shiu, L., Chang, L., Sheu, H., & Kuo, K. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700044 · Cited by 49 · see citing works

Mammalian Target of Rapamycin–Dependent Acinar Cell Neoplasia after Inactivation of Apc and Pten in the Mouse Salivary Gland: Implications for Human Acinic Cell Carcinoma

Diegel, C. R., Cho, K. R., El‐Naggar, A. K., Williams, B. O., & Lindvall, C. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1758 · Cited by 49 · see citing works

Signal Transduction in Transgenic Mouse Models of Human Breast Cancer—Implications for Human Breast Cancer

Marcotte, R., & Muller, W. J. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9087-3 · Cited by 48 · see citing works

Mouse Models of Breast Cancer

Sakamoto, K., Schmidt, J. W., & Wagner, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_3 · Cited by 48 · see citing works

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer

Pontier, S. M., Huck, L., White, D. E., Rayment, J. H., Sanguin‐Gendreau, V., Hennessy, B. T., Zuo, D., St‐Arnaud, R., Mills, G. B., Dedhar, S., et al. (2010) · Oncogene · doi:10.1038/onc.2010.86 · Cited by 47 · see citing works

Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.

Hewitt, S. C., Bocchinfuso, W. P., Zhai, J. L., Harrell, C., Koonce, L., Clark, J. A., Myers, P., & Korach, K. S. (2002) · PubMed · Cited by 46 · see citing works

TGF‐β promotes cell death and suppresses lactation during the second stage of mammary involution

Bierie, B., Gorska, A. E., Stover, D. G., & Moses, H. L. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21646 · Cited by 46 · see citing works

Epithelial Protein-Tyrosine Phosphatase 1B Contributes to the Induction of Mammary Tumors by HER2/Neu but Is Not Essential for Tumor Maintenance

Balavenkatraman, K. K., Aceto, N., Britschgi, A., Mueller, U., Bence, K. K., Neel, B. G., & Bentires‐Alj, M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0198 · Cited by 46 · see citing works

mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis

Morrison, M. M., Young, C. D., Wang, S., Sobolik, T., Sanchez, V. M., Hicks, D. J., Cook, R. S., & Brantley‐Sieders, D. M. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005291 · Cited by 46 · see citing works

Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer

Bui, T., Rennhack, J. P., Mok, S., Ling, C., Perez, M., Roccamo, J., Andrechek, E. R., Moraes, C., & Muller, W. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.004 · Cited by 45 · see citing works

An EGR2/CITED1 Transcription Factor Complex and the 14-3-3σ Tumor Suppressor Are Involved in Regulating ErbB2 Expression in a Transgenic-Mouse Model of Human Breast Cancer

Dillon, R. L., Brown, S. T., Ling, C., Shioda, T., & Muller, W. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00866-07 · Cited by 45 · see citing works

p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis

Yallowitz, A. R., Alexandrova, E. M., Talos, F., Xu, S., Marchenko, N. D., & Moll, U. M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2013.199 · Cited by 44 · see citing works

Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer

Wang, Q., Li, S.-H., Wang, H., Xiao, Y. Q., Şahin, Ö., Brady, S. W., Li, P., Ge, H., Jaffee, E. M., Muller, W. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1339-t · Cited by 43 · see citing works

p120-catenin is essential for terminal end bud function and mammary morphogenesis

Kurley, S. J., Bierie, B., Carnahan, R. H., Lobdell, N. A., Davis, M. A., Hofmann, I., Moses, H. L., Muller, W. J., & Reynolds, A. B. (2012) · Development · doi:10.1242/dev.072769 · Cited by 43 · see citing works

Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells

Kim, A., Liu, B., Ordonez‐Ercan, D., Alvarez, K. M., Jones, L. D., McKimmey, C. C., Edgerton, S. M., Yang, X.-H., & Thor, A. D. (2005) · Breast Cancer Research · doi:10.1186/bcr1281 · Cited by 42 · see citing works

Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy

Hirukawa, A., Singh, S., Wang, J. H., Rennhack, J. P., Swiatnicki, M., Sanguin‐Gendreau, V., Zuo, D., Daldoul, K., Lavoie, C. A., Park, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.105 · Cited by 41 · see citing works

Molecular alterations in sporadic breast cancer

Lerebours, F., & Lidereau, R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00191-3 · Cited by 41 · see citing works

Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis

Anisimov, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00262-7 · Cited by 41 · see citing works

A novel role for 14–3–3σ in regulating epithelial cell polarityPreprint

Ling, C., Zuo, D., Xue, B., Muthuswamy, S. K., & Muller, W. J. (2010) · Genes & Development · doi:10.1101/gad.1896810 · Cited by 41 · see citing works

Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells

Chatterjee, S., Seifried, L. A., Feigin, M. E., Gibbons, D. L., Scuoppo, C., Lin, W., Rizvi, Z. H., Lind, E. F., Dissanayake, D., Kurie, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034343 · Cited by 40 · see citing works

Gene targeting of ErbB3 using a Cre‐mediated unidirectional DNA inversion strategy

Qu, S., Rinehart, C., Wu, H., Wang, S. E., Carter, B., Xin, H., Kotlikoff, M. I., & Arteaga, C. L. (2006) · genesis · doi:10.1002/dvg.20243 · Cited by 38 · see citing works

Dual role of AP-2? in ErbB-2-induced mammary tumorigenesis

J�ger, R., Friedrichs, N., Heim, I., B�ttner, R., & Schorle, H. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-4815-x · Cited by 38 · see citing works

Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer

Menezes, M. E., Das, S. K., Emdad, L., Windle, J. J., Wang, X., Sarkar, D., & Fisher, P. B. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800249-0.00008-1 · Cited by 37 · see citing works

neu/erbB-2oncogene in mouse mammary tumorigenesis

Howard, B. A. (2000) · Breast Cancer Research · doi:10.1186/bcr-2000-66673

A Mouse Model for Breast Cancer Induced by Amplification and Overexpression of the neu Promoter and Transgene

Weinstein, E. J., Kitsberg, D., & Leder, P. (2000) · Molecular Medicine · doi:10.1007/bf03401930 · Cited by 34 · see citing works

Gene Expression Profiling of Neu-induced Mammary Tumors from Transgenic Mice Reveals Genetic and Morphological Similarities to ErbB2-expressing Human

Cancers, B., Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003)

A Genetic Dissection of the Role of the ErbB2 IN eu Receptor Tyrosine Kinase in Development and Tumorigenesis in Transgenic Mice.

Andrechek, E. R. (2003) · MacSphere (McMaster University) · doi:10.71548/7753

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.

Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003) · PubMed · Cited by 65 · see citing works